December 1, 2007
By:Sarah Houlton
One of industry's main complaints is that delaying the introduction of new medicines is a particularly simple way of saving money
 |
December 1, 2007
By:Joanna Breitstein
Science is the lifeblood of pharma, of course. But these days, science isn't just what you produce in your own labs. It's what you can license, buy, partner on, or gain through acquisition. Which means that, increasingly, deals are the lifeblood of pharma.
|
November 1, 2007
By:Jill Wechsler
FDAAA aims to restore public trust in drug safety regulation but may curb investment in R&D
|
November 1, 2007
By:Patrick Clinton
A hospital safety expert says it's now possible to completely eliminate certain adverse events. Pharma can't claim the same yet, but is it time for us to start imagining a time when we can "benchmark perfection"?
|
 | November 1, 2007
By:Mike Maguire
In this age of new media, social networking, blogs, and cyber-clutter, it's easy to forget the appeal of the real—of things that you can hold in your hand and engage with physically. But make no mistake, despite all of the high-tech tools available to us, advertising still relies on evoking an emotional response by tickling the human senses.
|
 | November 1, 2007
By:Tammy Prouty
Most people exhibit characteristics of both visual and verbal learning styles and learn most effectively when information is presented through a combination of the two
|
November 1, 2007
By:Sander A. Flaum
We have nothing to fear but the fear of change (with apologies to the wise Franklin D. Roosevelt). But we must get over that if we hope to make a real difference.
|
November 1, 2007
By:Sarah Houlton
Will CROs continue to operate in India, or will Novartis' pullout send them farther East?
|
| 
PharmExec Blog
Follow Us
RSS
Bookstore
What's the best managed pharma? Professor Bill Trombetta of Saint Joseph's University attempts to answer the question in Pharm Exec's Industry Audit.
The most respected annual ranking of top 50 pharmaceutical companies by prescription drug sales... Who's in, who's back, and who's out?
Super Reps book trilogy by Dr. Lou Sawaya MD, MBA
Don't miss this Podcast series commemorating the 20th anniversary of HBA's Woman of the Year Award with interviews spanning two decades of change makers.
Conducting clinical trials in emerging regions can give you the edge. Five Quintiles experts share their insights into navigating the global regulatory landscape.